Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk
- PMID: 20856886
- PMCID: PMC2938354
- DOI: 10.1371/journal.pone.0012598
Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk
Abstract
Background: The risk of sexual transmission of HIV-1 is strongly associated with the level of HIV-1 RNA in plasma making reduction in HIV-1 plasma levels an important target for HIV-1 prevention interventions. A quantitative understanding of the relationship of plasma HIV-1 RNA and HIV-1 transmission risk could help predict the impact of candidate HIV-1 prevention interventions that operate by reducing plasma HIV-1 levels, such as antiretroviral therapy (ART), therapeutic vaccines, and other non-ART interventions.
Methodology/principal findings: We use prospective data collected from 2004 to 2008 in East and Southern African HIV-1 serodiscordant couples to model the relationship of plasma HIV-1 RNA levels and heterosexual transmission risk with confirmation of HIV-1 transmission events by HIV-1 sequencing. The model is based on follow-up of 3381 HIV-1 serodiscordant couples over 5017 person-years encompassing 108 genetically-linked HIV-1 transmission events. HIV-1 transmission risk was 2.27 per 100 person-years with a log-linear relationship to log(10) plasma HIV-1 RNA. The model predicts that a decrease in average plasma HIV-1 RNA of 0.74 log(10) copies/mL (95% CI 0.60 to 0.97) reduces heterosexual transmission risk by 50%, regardless of the average starting plasma HIV-1 level in the population and independent of other HIV-1-related population characteristics. In a simulated population with a similar plasma HIV-1 RNA distribution the model estimates that 90% of overall HIV-1 infections averted by a 0.74 copies/mL reduction in plasma HIV-1 RNA could be achieved by targeting this reduction to the 58% of the cohort with plasma HIV-1 levels ≥4 log(10) copies/mL.
Conclusions/significance: This log-linear model of plasma HIV-1 levels and risk of sexual HIV-1 transmission may help estimate the impact on HIV-1 transmission and infections averted from candidate interventions that reduce plasma HIV-1 RNA levels.
Conflict of interest statement
Figures

Similar articles
-
Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.PLoS One. 2009;4(4):e5272. doi: 10.1371/journal.pone.0005272. Epub 2009 Apr 30. PLoS One. 2009. PMID: 19404392 Free PMC article. Clinical Trial.
-
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.Lancet. 2010 Jun 12;375(9731):2092-8. doi: 10.1016/S0140-6736(10)60705-2. Epub 2010 May 26. Lancet. 2010. PMID: 20537376 Free PMC article.
-
HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy.J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):579-84. doi: 10.1097/QAI.0000000000001019. J Acquir Immune Defic Syndr. 2016. PMID: 27070123 Free PMC article.
-
Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression.AIDS. 2008 Oct 18;22(16):2179-85. doi: 10.1097/QAD.0b013e328312c756. AIDS. 2008. PMID: 18832881 Free PMC article. Review.
-
Using HIV viral load to guide treatment-for-prevention interventions.Curr Opin HIV AIDS. 2012 Mar;7(2):117-24. doi: 10.1097/COH.0b013e32834fe8ff. Curr Opin HIV AIDS. 2012. PMID: 22258501 Review.
Cited by
-
Optimal Treatment Strategies in the Context of 'Treatment for Prevention' against HIV-1 in Resource-Poor Settings.PLoS Comput Biol. 2015 Apr 30;11(4):e1004200. doi: 10.1371/journal.pcbi.1004200. eCollection 2015 Apr. PLoS Comput Biol. 2015. PMID: 25927964 Free PMC article.
-
HIV-1 prevention for HIV-1 serodiscordant couples.Curr HIV/AIDS Rep. 2012 Jun;9(2):160-70. doi: 10.1007/s11904-012-0114-z. Curr HIV/AIDS Rep. 2012. PMID: 22415473 Free PMC article. Review.
-
Perceived risk versus objectively measured risk of HIV acquisition: a cross-sectional study among HIV-negative individuals in Serodiscordant partnerships with clients attending an Urban Clinic in Uganda.BMC Public Health. 2019 Nov 29;19(1):1591. doi: 10.1186/s12889-019-7929-0. BMC Public Health. 2019. PMID: 31783826 Free PMC article.
-
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission.Sci Transl Med. 2011 Apr 6;3(77):77ra29. doi: 10.1126/scitranslmed.3001888. Sci Transl Med. 2011. PMID: 21471433 Free PMC article.
-
HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders.Nat Med. 2015 Oct;21(10):1139-41. doi: 10.1038/nm.3932. Epub 2015 Aug 31. Nat Med. 2015. PMID: 26322580 Free PMC article.
References
-
- Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342:921–929. - PubMed
-
- Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48–57. - PubMed
-
- Gurunathan S, Habib RE, Baglyos L, Meric C, Plotkin S, et al. Use of predictive markers of HIV disease progression in vaccine trials. Vaccine. 2009;27:1997–2015. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical